SF3B1 and myelodysplastic syndrome: Thus, although disease-related shifts in CD4+/CD8+ T-cell differentiation were noticeable irrespective of SF3B1 mutation status, naïve CD4+ T cells in SF3B1K700E LR-MDS displayed subtle immunophenotypic differences indicative of less recent activation.